Found 165 matching trials
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis PHASE3 The purpose of this study is to see if there is a difference in survival be...
Show More Location
Akademiska Sjukhuset (Uppsala University Hospital)
Learn More & Join Trial
A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer PHASE1 This study will evaluate the safety of administering a peptide vaccine cons...
Show More Location
Duke Comprehensive Cancer Center
Learn More & Join Trial
Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer PHASE3 RATIONALE: Clodronate may be effective in preventing the spread of cancer t...
Show More Location
CCOP - Mayo Clinic Scottsdale Oncology Program
Learn More & Join Trial
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis PHASE2 This is the first randomized trial comparing Early post-operative intraperi...
Show More Status
Active Not Recruiting
Location
University of Miami
Learn More & Join Trial
Proactive Management of Endoperitoneal Spread in Colonic Cancer PHASE3 This study aims to determine the oncological effectiveness, compared to sta...
Show More Location
ASST Nord Milano P.O. Città di Sesto S. Giovanni
Learn More & Join Trial
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy PHASE2 To assess the safety of treating men with oligometastatic prostate cancer w...
Show More Location
Johns Hopkins Sibley Memorial Hospital
Learn More & Join Trial
Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC PHASE2 To explore the efficiency and safety of Tislelizumab combinated with carbop...
Show More Location
Multiple Locations
Learn More & Join Trial
Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform N/A Patients with stage II-III Triple negative breast cancer (TNBC) candidates ...
Show More Location
Vall d'Hebron Institute of Oncology
Learn More & Join Trial
EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR) PHASE2 The investigators aim to investigate whether incorporating on-treatment EBV...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial